期刊文献+

未足月胎膜早破不同孕周及潜伏期对母婴妊娠结局的影响 被引量:15

Effect of different gestational weeks and latent period on pregnancy outcomes in patients with preterm premature rupture of membrane
下载PDF
导出
摘要 目的探讨未足月胎膜早破(PPROM)破膜孕周及不同潜伏期长短对妊娠结局的影响及临床意义。方法回顾性分析434例孕28~37周PPROM孕产妇和新生儿的临床资料,根据孕产妇发生PPROM的孕周将所有病例分为28~33周(A组)和34~37周(B组)两组,并根据潜伏期分别将两组患者分为﹤48h和﹥48h。总结其临床特征及围产结局。结果 B组母婴结局优于A组,差异有统计学意义(P<0.05)。A组潜伏期大于48h孕妇分娩后发生产褥感染和绒毛膜羊膜炎概率高于潜伏期小于48h孕妇(P<0.05),潜伏期大于48h胎儿窒息、肺部感染以及呼吸窘迫综合征的发生率优于潜伏期小于48h者(P<0.05)。B组潜伏期大于48h孕妇分娩后发生产褥感染和绒毛膜羊膜炎概率高于潜伏期小于48h孕妇(P<0.05),新生儿各项指标组内对比差异无统计学意义(P>0.05)。结论针对未足月胎膜早破发生的相关因素采取相应的临床处理,增加孕期保健,综合治疗,可减少母婴病率,改善孕妇及早产儿预后。 Objective To study the effect and clinical significances of different gestational weeks and latent period on pregnancy outcomes in preterm premature rupture of membrane (PPROM). Methods According to gestational weeks, 434 patients with PPROM of 28~37 weeks were divided into group A (28~33 weeks) and group B (34~37 weeks), which were further divided into 48 h subgroup and 48 h subgroup according to latent period. The clinical features and perinatal outcome were analyzed. Results The pregnancy outcome was significantly better in group B than group A (P0.05). In group A, the incidences of puerperal infection and chorioamnionitis were significantly higher in 48 h subgroup than 48 h subgroup (P0.05), while the incidences of fetal distress, pulmonary infection and respiratory distress syndrome were significantly lower in 48 h subgroup (P0.05) than 48 h subgroup. In group B, the incidences of puerperal infection and chorioamnionitis were significantly higher in 48 h subgroup than 48 h subgroup (P0.05), while no statistically significant difference was found in the indexes of neonates (P0.05). Conclusion Adopting the relative clinical treatment and strengthening the gestataional health, based on the relative factors leading to preterm premature rupture of membranes, may reduce the morbidity of maternal and neonates and improve the prognosis of preterm neonates.
出处 《海南医学》 CAS 2012年第22期46-48,共3页 Hainan Medical Journal
关键词 未足月胎膜早破 孕周 潜伏期 妊娠结局 Preterm premature rupture of membrane Gestational weeks Latent period Pregnancy outcomes
  • 相关文献

参考文献8

二级参考文献26

  • 1李玮,漆洪波.未足月胎膜早破的研究进展[J].中华围产医学杂志,2005,8(1):57-59. 被引量:157
  • 2蔡查清.未足月胎膜早破256例临床分析.中华现代妇产科杂志,2006,3(11):39-39.
  • 3Shaarawy M, EL Minawi AM. Prolactin and calcidtropic hormones in preterm premature of membraness [J]. Int Gynecol Obstet, 2004,84 : 200.
  • 4Parry S, Strauss JF 3rd. Premature rupture of the fetal membranes [J]. N Engl J Med, 1998,338 (10) : 663-670.
  • 5Morris JM, Roberts CL, Crowther CA, et al. Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) Trial [J]. BMC Pregnancy Childbirth, 2006,6: 9.
  • 6Pasquier JC, Picaud JC, Rabilloud M, et al. Neonatal outcomes after elective delivery management of preterm premature rupture of the membranes before 34 weeks' gestation [J]. Eur J Obstet Gynecol Reprod Biol, 2009,143 (1):18-23.
  • 7Pasquier JC, Doret M. Complications and monitoring of the latency period after a preterm premature rupture of the fetal membranes: literature review [J]. J Gynecol Obstet Biol Reprod (Paris), 2008,37(6):568-578.
  • 8Mingione M J, Pressman EK, Woods JR. Prevention of PPROM: current and future strategies [J]. J Matern Fetal Neonatal Med, 2006, 19(12) : 783-789.
  • 9Mercer BM. Preterm premature rupture of the membranes [J]. Obstet Gynecol, 2003,101 ( 1 ) : 178-193.
  • 10Lieman JM, Brumfield CG, Carlo W, et al. Preterm premature rupture of membranes: is there an optimal gestational age for delivery [J]? Obstet Gynecol, 2005,105(1):12- 17.

共引文献69

同被引文献105

  • 1崔小宁,白婧.妊娠晚期未足月胎膜早破208例临床分析[J].今日健康,2016,15(3):39-39. 被引量:2
  • 2朱宇,余艳红,龚时鹏.孕≤34周胎膜早破的妊娠结局[J].实用临床医学(江西),2007,8(2):69-71. 被引量:1
  • 3许向红.胎膜早破的诊断及标准护理[J].现代护理,2011,3(3):149.
  • 4Awadalla AW, Ohaeri JU, Gholoum A, et al. Factors associated with quality of life of outpatients patients with breast cancer and gyneco- logic cancers and their family caregivers: a controlled study [J]. BMC Cancer, 2011, 12(7): 1021-1022.
  • 5McQucllon RP, Thaler HT, Celia D, et al. Quality of life outcomes from a randomized trial of cisplatin versus cisplatin plus palitaxcl in advance cervical Gynecology Oncology Group study [J]. Gynecol Oncol, 2010, 102 (2): 296297.
  • 6Skolarikos A, Mitsogiannis H, Deliveliotis C. Indications, predic- tion of success, and methods to improve outcome of shock wave lithotripsy of renal and upper ureteral calculi [J]. Arch Ital Uml An- tirol, 2010, 82(1): 56-63.
  • 7Wedd A, Cunningham D, Scarffe JH, et al. Randomized trial com- paring epirubicin, cisilatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophageal gastric can- cer.[J]. J Clin Oncol, 2011, 15(10): 261-267.
  • 8Wdck JK, Kopecky K J, Appelbaum FR, et al. A randomized investi- gation of High-dose versus standard-dose cytosine arabinoside with daunorubicin in patients patients with previously untreated acute myeloid leukemia: a Southwest Oneolor Group study [J]. Blood, 2012, 88(51): 833-834.
  • 9Simforoosh N, Basiri A, Dancsh A, ct al. Laparoscopic management of urcteral calculi: a report of 123 cases [J]. Urology Journal, 2009, 4(3): 138-141.
  • 10Lee T, Carpenter MW, Heber WW, et al. rmpremature rupture of membranes: risks of recurrent complications in the next pregnancy among a population-based sample of gravid women [J]. Am J Ob- stet Gynecol, 2003, 188(1): 209-213.

引证文献15

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部